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ABSTRACT
MicroRNAs (miRNAs) are non-coding small RNAs of
 22 nt that regulate the gene expression by base
pairing with target mRNAs, leading to mRNA cleav-
age or translational repression. It is currently esti-
mated that miRNAs account for  1% of predicted
genes in higher eukaryotic genomes and that up to
30% of genes might be regulated by miRNAs.
However, only very few miRNAs have been function-
ally characterized and the general functions of
miRNAs are not globally studied. In this study, we
systematically analyzed the expression patterns of
miRNA targets using several public microarray
profiles. We found that the expression levels of
miRNA targets are lower in all mouse and Drosophila
tissues than in the embryos. We also found miRNAs
more preferentially target ubiquitously expressed
genes than tissue-specifically expressed genes.
These results support the current suggestion that
miRNAs are likely to be largely involved in embryo
development and maintaining of tissue identity.
INTRODUCTION
MicroRNAs (miRNAs), encoded in the chromosomal DNA
and transcribed as longer stem–loop precursors, termed
pri-miRNAs, are non-coding small (21–23 nt) RNAs that
regulate the expression of target mRNAs [reviewed in
(1–4)]. Upon transcription, pri-miRNA is converted to mature
miRNA duplex through sequential processing by RNase III
family of endonucleases Drosha and Dicer (3,4). One strand
of the processed duplex is incorporated into a silencing
complex and guided to target sequences by base pairing
[reviewed in (5,6)]. This results in the cleavage of target
mRNAs or repression of their productive translation (5,6).
In the past few years, several hundred miRNAs were
identiﬁed in animals and plants. It is currently estimated
that miRNAs account for  1% of predicted genes in higher
eukaryotic genomes (7).
Despite the large number of identiﬁed miRNAs, only a
handful of them have been functionally characterized. For
example, lin-4 and let-7 regulate the timing of larval develop-
ment in Caenorhabditis elegans (8,9). Lsy-6 and miR-273 act
sequentially to control the left/right asymmetric gene expres-
sion in C.elegans chemosensory neurons (10). Bantam pro-
motes cell proliferation and inhibits apoptosis in Drosophila
(11). MiR-14 suppresses cell death and regulates fat metabo-
lism (12). MiR-181 potentiates B-cell differentiation (13).
These ﬁndings, together with the complicated expression
patterns and large number of predicted targets, imply that
miRNAs may regulate a broad range of physiological and
developmental processes.
Identiﬁcation of the targets of each miRNA is crucial for
understanding the biological function of miRNAs. Accumu-
lating empirical evidence has revealed the importance of
the 5-terminal segment of miRNAs with 6–8 nt in length,
called ‘seed’ region, for miRNA function (14–17). For
example, systematical single nucleotide mutation studies
demonstrated that base pairing of miRNAs to their targets
with 7 nt at the 5-terminus of miRNAs from position 2 to
position 8 is essential and sometimes sufﬁcient for miRNAs
to knockdown their target expression (14). Based on these
discoveries, several computational methods have been devel-
oped to search for miRNA targets (18–27). Most of these
methods have been biologically validated and proved to be
very efﬁcient and accurate. The accuracy of these methods
has also been proved by large scale gene expression proﬁle
studies (28,29). In one study, Lim et al. (28) reported
that transfections of miR-1 and miR-124 into HeLa cells,
respectively caused down-regulation of large numbers of
target mRNAs and majority (76 and 88%, respectively)
of down-regulated mRNAs showed a segment with 6 nt
complementary to the 50-terminus of the transfected miRNAs
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demonstrated that knockdown of miRNA-122 by intravenous
administration of miRNA ‘antagomirs’ led to up-regulation
and down-regulation of a large number of genes in liver.
They found that the 30-untranslated regions (30-UTRs) of
up-regulated genes are strongly enriched in miRNA-122
‘seed’-match motifs, whereas down-regulated genes are
depleted in these motifs (29).
These methods have yielded a large number of candidate
targets in both plants and animals. The estimated human
miRNA targets can account for up to one-third of human
genes (23). The diversity and abundance of miRNA targets
reﬂect that miRNAs and their targets appear to form a
complex regulatory network. For example, a single miRNA
can regulate hundreds of mRNAs and a single mRNA can
be targeted by several different miRNAs.
Systematical analysis of gene expression proﬁles has been
proved to be valuable for studies on diverse biological pro-
cesses (30–33). Based on its biochemical function, the
biological functions of a miRNA should depend on the
combination of its action to each of all its targets for their
expression. Accordingly, Farh et al. (34), Stark et al. (35)
and Sood et al. (36) have recently found a clear correlation
of the expression of miRNAs and their targets through
analysis of mRNA target expression proﬁles and in situ
hybridization. In this study, we undertook a global analysis
of the expression of mRNA targets in human, mouse and
Drosophila using several public gene expression datasets
(37–39). To our surprise, we found that the average expres-
sion levels of the total targets of all miRNAs are signiﬁcantly
different in distinct tissues compared to the expression of the
total genes. For example, we found that the expression levels
of miRNA targets are signiﬁcantly lower in all mouse mature
tissues and Drosophila later life stages than in the embryos.
We also found that miRNA targets are more ubiquitously
expressed.
MATERIALS AND METHODS
Stand-alone Java programs or Perl scripts were used where
necessary to facilitate the following analyses.
Datasets used in this study
The datasets used in this study include two complete lists of
human miRNA targets published by Lewis et al. (23) and
Krek et al. (21), one complete list of human and mouse
miRNA targets published by John et al. (19), two complete
lists of Drosophila miRNA targets published by Enright
et al. (18) and Stark et al. (26), a microarray expression
dataset for more than 10 000 human genes across 52 tissues
and cell lines (38), a microarray expression dataset for nearly
40 000 known and predicted mRNAs in 55 mouse tissues (39)
and a microarray expression data for nearly one-third of all
Drosophila genes during the whole life-cycle (37).
All miRNA target datasets were downloaded from the most
recently updated websites. The datasets published by Lewis
et al. (23) and Krek et al. (21) contain human miRNA targets
but not mouse miRNA target. To get mouse miRNA targets,
we mapped the human miRNA targets to the orthologous
genes in mouse genome. To do so, we ﬁrst converted the
human gene IDs from the datasets published by Lewis et al.
(23) and Krek et al. (21) to NCBI GeneIDs using ID Converter
(http://idconverter.bioinfo.cipf.es/). To obtain the correspond-
ing mouse orthologous gene pairs, we queried the homoloGene
data ﬁle downloaded from HomoloGene (ftp://ftp.ncbi.nih.gov/
pub/HomoloGene/) using the human genes.
For the human gene microarray dataset (38), we removed
some samples which derived from the same or similar tissues
in order to avoid over-representation of these samples for the
analysis. For example, several brain samples were present in
the dataset, we removed most of them. Totally 41 human
tissues were analyzed.
As the mouse microarray gene chips were designed to
detect 40000 known and predicted mouse mRNAs (39), it
is expected that many predicted mRNAs should not be
expressed. Totally 21622 genes could be detected in at
least one tissue in the microarray gene chips. The rest (almost
half) of them were not detected in any tissues. Therefore,
only 21622 genes were analyzed in this study.
Ranking of miRNA target genes
To study the correlation of the expression of miRNAs and
their targets, we analyzed the microarray expression data
containing  10000 genes published by Johnson et al. (38)
across 41 human tissues by ranking each gene over all tissues
according to its expression level in the respective tissue as
described previously (28). A lower rank number represents
less expression level. For example, if a gene is expressed
less in a deﬁned tissue than in any other tissues, the rank
number of this gene in this tissue is 1. Similarly, rank number
41 means that the expression level of a gene in the tissue is
higher than that in any other tissues. We then mapped
miRNA targets to the genes in the microarray dataset. The
miRNA targets we used in this analysis are from the datasets
published by Lewis et al. (22) and John et al. (19), respec-
tively. We only chose the miRNAs, which have more than
50 targets found in the microarray dataset for further analysis.
On average, 180 targets per miRNA could be found in the
microarray dataset. For each miRNA, in each tissue, we
obtained a rank number of each of its targets.
To facilitate a more global view, we grouped the genes into
two sets, one with lower half of rank numbers and the other
with higher half. When there is an odd number of a rank, the
middlemost rank is excluded. In our speciﬁc example with
41 tissue samples, one set consists of ranks 1–20 and the
other from 22–41, excluding rank 21. For any miRNA in
any tissue, we counted the total number of its targets within
lower-rank set and divided it by the total number of its targets
within higher-rank set to yield the calculated rank ratio,
RR. For example, for a miRNA in the 41-tissue set, RR ¼
NRank1–20/NRank22–41. The RR value is an indicator of the
preferential tissue expression of a given miRNA’s target
genes. An RR value greater than one means that the majority
of expressed targets of a miRNA in this tissue have a lower
expression level than the median level of expression of the
miRNA’s targets across all the tissues. If the RR value of a
miRNA is greater in a particular tissue than that in any others,
the expression level of the targets of this miRNA in this tissue
is very likely to be the lowest among the 41 human tissues.
We also did the same analysis for total genes presented in
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miRNA in a tissue was normalized by the RR value of total
genes in the same tissue and then plotted as a function of
tissues and miRNAs, respectively. The RR value provides a
global descriptor of the tissue distribution of a miRNA’s
target genes rather than the expression levels of individual
genes. It does not provide gene-speciﬁc information but
allows the extraction of global trends of a group of genes
(miRNA target genes) amid the noisy data for individual
genes. This method was also used to analyze a microarray
dataset containing 55 mouse samples. In this case, RR ¼
NRank1–27/NRank29–55.
Comparison of the expression level of miRNA targets in
the embryos of mouse and Drosophila with that in their
mature tissues
To explore the difference of the expression level of the total
targets of all available miRNAs in mouse mature tissues
from that in 12.5-day mouse embryo, we compared the
absolute expression value of each gene between tissues and
the embryo to determine if a gene has a higher or lower
expression level in a tissue than in embryo. We then
calculated the ratio of lower-expressed targets to the higher-
expressed targets in each tissue (termed Rmirna).
To determine the statistical signiﬁcance of the observation,
we performed resampling statistical tests. A more detailed
explanation of randomization tests was described previously
(40). In each test, we randomly picked up the same number
of genes as the number of miRNA targets from total genes.
We calculated the ratio of lower-expressed genes to higher-
expressed genes in this sub-pool and deﬁned it as Rrandom.
We performed the randomly picking test for 5000 tests and
counted the number of times (N) when Rrandom > Rmirna.
We deﬁned P-value as N/5000. If P < 0.05, we thought
that the number of lower-expressed miRNA targets is
signiﬁcantly more than that of higher-expressed miRNA
targets. We rejected the hypothesis if the P < 0.05.
We used three sets of miRNA targets, respectively, for
this analysis. They are the mouse miRNA dataset published
by John et al. (19) and the human miRNA datasets published
by Lewis et al. (23) and Krek et al. (21), respectively. Human
miRNA targets were converted to mouse orthologous for the
analysis. We performed correlation analysis of the results
obtained from each of the three datasets and calculated the
correlation coefﬁcient using R (http://www.r-project.org/).
A similar method was used to compare the expression of
miRNA targets in the different periods of Drosophila life
cycle with that in the 23–24 h embryo using a microarray
dataset published by Arbeitman et al. (37), except that the
ratio of number of miRNA targets whose expression level
in a deﬁned period is 2-fold lower than that in 23–24 h
embryo to that of miRNA targets whose expression level is
two times higher than that in 23–24 h embryo was repre-
sented. The statistical analysis for this set was conducted as
described above.
Analysis of the tissue-specificity of miRNA
target expression
Using the microarray database published by Zhang et al. (39),
in which 21622 mouse genes including 2276 miRNA targets
published by John et al. (19) were expressed in at least one
tissue, we analyzed the tissue-speciﬁcity of miRNA target
expression. The mouse genes are classiﬁed into 55 groups
according to the number of tissues (1–55) in which a gene
was expressed. The total numbers of miRNA targets and
total genes in each group were counted, respectively. The
percentage of miRNA targets to the total genes in each
group was calculated and compared to the percentage
(10.52%) of the total miRNA targets (2276) to the total
genes (21622) for determining if the miRNA targets are
enriched in or excluded from the respective group.
RESULTS
Expression level of miRNA targets is tissue-dependent
Since the function of a miRNA depends on the combination
of its actions to all of its targets for their expression, to under-
stand the global role of these numerous miRNAs, we
undertook a global analysis of the expression of mRNA
targets in human, mouse and Drosophila using several public
datasets. We ﬁrst analyzed the microarray expression data
containing  10000 genes over 41 human tissues published
by Johnson et al. (38). We compared the relative expression
level of the total targets of individual miRNAs across the
41 human tissues. Since each miRNA has many targets and
the absolute expression levels of these targets are very differ-
ent, the contribution of each target to the result should be
different if we simply use the average expression level of
these targets for comparison. To make each target equally
contribute to the comparison, we ranked each gene over
41 human tissues according its expression levels in the
respective tissues (see Materials and Methods). A lower
rank number means a lower expression level. For each
miRNA, in each tissue, we counted the total number of its tar-
gets (23) at each rank position (Supplementary Table S1). By
comparing the distribution of the rank number of the targets
between different tissues, we could ﬁnd the relative expres-
sion levels of the total targets of a miRNA in each tissue
compared to other tissues. This method could avoid the effect
of the bias of the absolute expression levels of the miRNA
targets on the analysis. Figure 1A shows a typical result for
the distribution of the rank number of miR-128a targets
(23) in liver and brain. In liver, the number of miR-128a
targets with a lower rank number is obviously more than
that of those with a higher rank number. In contrast, in
brain, the result is reversed. This suggests that the overall
expression level of the targets of miR-128a in liver is lower
than that in brain. To obtain a quick overview, we grouped
the targets into two sets, one with rank numbers from 1–20
and the other with rank numbers from 22–41 (see inset in
Figure 1A). We then calculated the RR value (see Materials
and Methods), NRank1–20/NRank22–41. A higher RR value of a
miRNA in a deﬁned tissue means that more targets of the
miRNA have a lower expression level (lower ranking num-
ber) in the tissue and less targets of the miRNA have a higher
expression level (higher ranking number) than that in most
tissues (more than half of the 41 tissues). A RR value more
than one means that the total number of the targets with a
rank number lower than 21 is more than the total number
of the targets with a rank number higher than 21, and suggests
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Figure 1. Ranking of the expression levels of miRNA targets in human tissues. Each miRNA target was ranked over 41 human tissue samples as described in the
‘Materials and Methods’ according to its expression level. The RR means the ratio of the total number (NRank1–20) of the miRNA targets with a lower rank
number (between 1 and 20) to the total number (NRank22–41) of the miRNA targets with a higher rank number (between 22 and 41). The RR value of the target
genes of each miRNA in a tissue is normalized by the RR value of the total genes in the same tissue. (A) Ranking results of the 295 targets of miR-128a in liver
and brain. (B) The RR values of the 55 miRNAs are plotted as a function of human tissues and cell lines. (C) The RR values over the 41 tissues and cell lines are
plotted as a function of miRNAs. (D) For each miRNA, the RR values of its targets were ranked across the 41 samples from higher value to lower value. The
miRNAs shown are highly specifically expressed in the indicated tissues as demonstrated previously for miRNA-1 and miRNA-133 in references (51,54);
miRNA-122 in reference (60); miRNA-16, miRNA-142, miRNA-181 and miRNA-223 in reference (61); miRNA-155 in references (52,53). The rank positions in
the indicated tissues were obtained and shown in the figure.
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Figure 2. Ranking of the expression levels of miRNA targets in mouse tissues. Each miRNA target gene was ranked over 55 mouse samples according to its
relative expression level in the respective sample as described in the ‘Materials and Methods’. The RR means the ratio of the total number (NRank1–27) of the
miRNA targets with a lower rank number (between 1 and 27) to the total number (NRank29–55) of the miRNA targets with a higher rank number (between 29 and
55). The RR value of the target genes of each miRNA in a tissue is normalized by the RR value of the total genes in the same tissue. (A) Comparison of the target
gene expressions (RR values) of the 141 miRNAs in bone marrow and 12.5-day embryo. (B) RR values over 141 miRNAs are plotted as a function of mouse
tissues. (C) The percentage of miRNAs, of which the total number (NRank1–27) of the targets with lower rank number (between 1 and 27) is more than the number
(NRank29–55) of the targets with higher rank number (between 29 and 55) (RR value >1).
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in the tissue is most likely to be lower than the median
expression level of the targets in all tissues. For example,
the RR value for miR-128a is 2.1 (197 targets/92 targets) in
liver and 0.57 (104 targets/184 targets) in brain, suggesting a
lower expression level of the miR-128a targets in liver than
that in brain. Totally, we analyzed 55 miRNAs, each of
which have at least 50 targets presented in the microarray
dataset (average 180 targets/miRNA), across 41 tissues. We
also did the same analysis for total genes present in the
microarray dataset. The RR values are shown in Supplemen-
tary Table S1. The RR value of the target genes for each
miRNA in a tissue was normalized by the RR value of the
total genes in the same tissue and then plotted as a function
of miRNAs and tissues, respectively (Figure 1B and C). As
expected, for each individual miRNA, the RR values in
different tissues are equally distributed around one (the num-
ber of the tissues with a RR value more than one is similar to
the number of the tissues with a RR value less than one)
(Figure 1B).
We next studied the correlation of the expression of
miRNAs and their targets using several public microRNA
microarray expression datasets. Because of the low accuracy
of the miRNA microarray expression proﬁling data, we
did not ﬁnd obvious correlation of the expression of miRNAs
and their target expression (data not shown). For example,
the miRNAs microarray expression proﬁles published by
different researchers are not consistent (41–50). Therefore,
we next focused on the miRNAs, which were highly speciﬁ-
cally expressed in one or a few tissues and whose expression
was highly conﬁrmed by different researchers through
northern blot analysis and/or cloning method (51–54).
To do so, for each miRNA, we further ranked the RR values
of their targets across the 41 tissues (from high value to low
value) and found the rank position for the tissues in which
the miRNA is highly speciﬁcally expressed. As shown in
Figure 1D, most miRNAs have a low rank number of their
target RR values in the tissues where they are speciﬁcally
expressed. This suggests that the expression of miRNAs has
a negative correlation with their target expression. However,
we noted that two miRNAs (miRNA-124a and miRNA-125b)
speciﬁcally expressed in brain do not show negative correla-
tion with their targets. For example, the RR values of
miRNA-124a and miRNA-125b in brain ranked at 38 and
Figure 3. Overall expression levels of miRNA targets in mouse tissues. The average expression levels of the miRNA targets and the total genes in each mouse
tissue were calculated using a microarray dataset (39), which contains 21622 mouse genes including 2276 miRNA targets published by John et al. (19).
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158 Nucleic Acids Research, 2007, Vol. 35, No. 135 of the 41 tissues, respectively. Interestingly, Sood et al.
found that for many miRNAs, their predicted targets are
up-regulated in neuronal tissues compared with most other
tissue types, without considering the expression patterns of
the miRNAs (36). We obtained a similar result (see below).
However, it is not clear if the unexpected higher expression
level of the targets of miRNA-124a and miRNA-125b in
brain, where the miRNAs are highly expressed, is caused
by the general high expression level of miRNA targets in
this tissue.
When we looked at the distribution of the RR values
in each tissue (Figure 1C), to our surprise, we found a
dramatic difference between different tissues. In some
tissues, the preponderance of miRNAs have a RR > 1.
Conversely, in some tissues, RR < 1 for an overwhelming
fraction of the miRNAs. This suggests that the overall
expression level of the total targets of all miRNAs is quite
lower in some tissues and higher in others. For example,
in bone marrow, 54 of the 55 miRNAs have a RR value
more than one, whereas in brain, none of them has a RR
value more than one, indicating that the overall expression
level of miRNA targets is lower in bone marrow but higher
in brain. Similar results were obtained when using the
miRNA targets published by John et al. (19) (Supplementary
Figure S1).
Expression levels of miRNA targets are lower in
mature tissues than in embryos in both
mammalian and fly
We next analyzed the expression of miRNA targets in
55 mouse samples using the gene expression proﬁle data
published by Zhang et al. (39) and the dataset of microRNA
targets published by John et al. (19). Similar to what we
found in human tissues, the RR value for all of the 141 miR-
NAs in mouse bone marrow is greater than one (Figure 2A),
suggesting that the expression level of miRNA targets in this
tissue is obviously lower than the median level across the
other tissues. A similar result was observed in other hemato-
poitic cells-rich or lymphocytes-rich tissues, such as thymus,
spleen and lymph node (Figure 2B and C). Most importantly,
the expression levels of miRNA targets in embryo, embryo
head and placenta are signiﬁcantly higher than that in most
mature tissues (Figure 2B and C). For example, in 12.5-day
embryo, all of the 141 miRNAs have a RR value below one.
To further conﬁrm the observation, we directly compared
the average expression value of the total 2276 miRNA targets
in the mouse tissues. Consisting with the result above derived
from ranking analysis, the average expression level of
miRNA target genes is higher in 12.5-day embryo than that
in any mature tissues except for cerebral cortex (Figure 3).
For example, the levels in bone marrow, spleen, thymus
D
Figure 4. Comparison of the expression levels of miRNA target genes in mouse tissues with that in 12.5-day embryo. (A–C) A microarray dataset containing
21622 genes over 55 mouse samples published by Zhang et al. (39) was used in this analysis. In each individual tissue, the expression level of each gene was
compared with that in 12.5-day embryo. The number of the miRNA targets whose expression level in a given tissue is lower than that in 12.5-day embryo
(N<E12.5) is divided by the number of miRNA targets with an expression level in the same tissue higher than that in 12.5-day embryo (N>E12.5). Three sets of
miRNA targets published by John et al. (19), Lewis et al. (23) and Krek et al. (21), respectively were analyzed. Each of them contains more than two thousand
miRNA targets found in the microarray dataset. As control, the same calculation was made for total genes. (D) Correlation between the data (N<E12.5/N>E12.5)
obtained using three different miRNA target datasets.
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than in 12.5-day embryo, whereas, the levels in neuronal
tissues, such as whole brain, middle brain, hindbrain,
cerebellum and trigeninus are slightly lower than in
12.5-day embryo or even higher (cerebral cortex) than in
12.5-day embryo. This consists with Sood et al.’s observation
(36) and our observation in human brain. This analysis
further conﬁrmed that, miRNA target expression levels are
A
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Figure 5. Analysis of the expression of miRNA targets in Drosophila.( A and B) A published microarray dataset (37) was analyzed for the comparison of the
expression levels of the miRNA targets during different periods of Drosophila life cycle. The total number of miRNA targets whose expression level is two times
lower than that in 23–24 h embryo (N<1/2·E23–24 h) was divided by the total number of those with expression level two times higher than that in 23–24 h embryo
(N>2·E23–24 h). Two sets of Drosophila miRNA targets published by Enright et al. (18) and Stark et al. (18,18,26), respectively were analyzed. As control, the
expression levels of the total genes were also analyzed by the same way. E, embryo; L, larva; M, pupae; Am, adult male and Af, adult female. (C) Correlation
between the data (N<1/2·E23–24 h/N>2·E23–24h) obtained using two different miRNA target datasets.
160 Nucleic Acids Research, 2007, Vol. 35, No. 1signiﬁcantly lower in most mature mouse tissues, except for
the neuronal tissues, than in embryos.
We then focused on the comparison of mouse mature
tissues to embryo. To do so, we counted the total number
of miRNA targets whose expression level is lower in a
given tissue than that in 12.5-day embryo (N<E12.5) and
divided it by the total number of miRNA targets whose
expression level is higher than that in 12.5-day embryo
(N>E12.5). As shown in Figure 4A, in all mature tissues, the
lower expressed target number is more than higher expressed
target number (N<E12.5/N>E12.5 > 1). As a control, we carried
out the same calculations for all genes. We see that, for all
tissues, the N<E12.5/N>E12.5 value of total genes is lower
than that of miRNA targets (Figure 4A). Resambling statisti-
cal tests (see ‘Materials and Methods’ for details) demon-
strated that the difference is signiﬁcant (P < 0.0002 for
almost all of the tissues, Supplementary Table S2). To further
conﬁrm the observation, we performed the same analysis with
the total miRNA targets published by Lewis et al. (23) and
Krek et al. (21), respectively. We found the similar patterns
(Figure 4B and C). Figure 4D shows that the data obtained
using the miRNA targets published by the three groups
respectively, are highly correlated. This supports both the
quality of the original data and our analysis method.
To determine if the observed expression pattern is con-
served in other species, we analyzed the published gene
expression proﬁle over 75 stages of the whole life cycle of
Drosophila (37). As shown in Figure 5A and B, compared
to 23–24 h embryo, while the ratio of lower expressed
miRNA targets to higher expressed miRNA targets remains
the same during embryo period, it dramatically increases
starting from larval periods and lasting to adulthood (P <
0.0002 for all larva and male adult, see Supplementary
Table S3 for more details). There is a clear correspondence
(R
2 ¼ 0.93) between the data calculated using the target
sets published by Enright et al. (18) and Stark et al. (26),
respectively (Figure 5C). This data supports the important
role of miRNAs for determining the timing of tissue differen-
tiation during larva period of Drosophila development and
maintaining the tissue identity during the adulthood.
It should be noted that the human microarray dataset (38)
we used in this study does not contain human embryo and a
large scale gene expression proﬁle containing human embryo
is not available. Consequently, we could not perform the
comparison of the expression levels of human miRNA targets
between human mature tissues and human embryos.
MiRNAs more frequently target ubiquitously expressed
genes than tissue-specific genes
We analyzed the tissue-speciﬁcity of miRNA target expres-
sion using the microarray data representing 21622 mouse
Figure 6. MiRNAs more frequently target ubiquitously expressed genes than tissue-restrictively expressed genes. A microarray dataset published by Zhang et al.
(39), which contains 21622 genes including 2276 miRNA targets (19), was used in this analysis as described in the ‘Materials and Methods’. The ratio of the
miRNA target genes to the total genes expressed in an indicated number of tissues was calculated.
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Each of these genes was expressed in at least one of the 55
mouse tissues (39). Both the 21622 genes and the 2276
miRNA targets were classiﬁed into 55 groups according to
the number of tissues (between 1 and 55) in which the gene
was expressed. We counted the numbers of miRNA targets
and total genes in each group, respectively. To determine if
the miRNA targets are enriched in or excluded from some
groups, we compared the percentage of miRNA targets
to the total genes in each group with the percentage
(10.5%) of the total miRNA targets (2276) to the total
genes (21 622). As shown in Figure 6, among the genes
that are expressed ubiquitously, the targets of miRNAs are
over-represented. For example, in genes found in groups
45–55 (i.e. genes found in almost all the tissues),  20% are
miRNA targets, around twice the fraction of miRNA targets
in the whole list of genes (10.5%). In contrast, among genes
that are expressed in a small number of tissues, miRNA
targets are under-represented. For example, among the
genes that are speciﬁcally expressed in only 1–4 tissues, the
fraction of miRNA targets present is about half or less than
that in the general gene population.
DISCUSSION
In this study, we found that the expression level of miRNA
targets in most mature tissues is signiﬁcantly lower than
that in embryos in both mammalian and ﬂy and that miRNAs
more frequently target ubiquitously expressed genes than
tissue-speciﬁc genes. These ﬁndings support the recent obser-
vations that some miRNAs play a most important role in
driving tissue terminal differentiation and maintaining tissue
identity. Previous studies suggest that 10 to 30% of human
genes are potential miRNA targets (19,22). However, analysis
of the speciﬁc gene ontology (GO) molecular function classi-
ﬁcation among the predicted targets could not reveal any spe-
ciﬁc biological functions of animal miRNAs since the animal
miRNA targets populated many GO functional categories
(19,22). Only  13% of mammalian miRNA targets predicted
by Lewis et al. were involved in development according to the
GO biological process categories (22). Failing to predict the
functions of miRNA targets through GO analysis may be sim-
ply caused by the evolving stage of the classiﬁcation of GO
function categories. Alternatively, on principle, the functions
of miRNAs could not be predicted by the GO function cate-
gories of their targets because the expression and therefore
the functions of their targets are proposed to be turned down
but not induced by miRNA expression and GO analysis can
only tell the function of a group of genes in a GO function
category when they are expressed or up-regulated but not
that when they are down-regulated. Our studies demonstrate
that statistical analysis of the expression of miRNA targets
may reﬂect the global functions of miRNAs. However, the bio-
logical signiﬁcance of the observation is not clear rightnow.
One proposal is that the statistically lower expression level
of miRNA targets in matured tissues than in embryo may
reﬂect the important role of miRNAs for embryo development
and for maintaining of the identity of matured tissues.
Up to now, the molecular mechanism determining the lower
expression level of miRNA targets in mature tissues than that
in embryos remains to be elucidated. One potential reason
is that the miRNA expression level is lower in embryos.
This is true for zebraﬁsh. Recently, Wienholds et al.h a v e
reported that most zebraﬁsh miRNAs were not detected during
early development (55). However, the results regarding to the
global expression patterns of miRNAs during mouse or
Drosophila embryo development are currently not available
although the differential expression of miRNAs in different
tissues were clearly demonstrated. Another possibility is that
the activity of miRNA machinery is lower in embryos than
in other tissues. For example, Yang et al.( 5 6 )r e p o r t e dt h a t
dicer, an important protein for miRNA biogenesis and
miRNA function, starts expression in 7-day old mouse
embryos and remains stable through 17-day embryos. How-
ever, maternal Dicer protein is probably present from fertiliza-
tion (57–59). In addition, a possible delay from miRNA
processing to target gene inactivation might also contribute
to the high level expression of miRNA targets in embryos.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
Funding to pay the Open Access publication charges for this
article was provided by National Research Council Canada.
Conflict of interest statement. None declared.
REFERENCES
1. Ambros,V. (2001) microRNAs: tiny regulators with great potential.
Cell, 107, 823–826.
2. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and
function. Cell, 116, 281–297.
3. Cullen,B.R. (2004) Transcription and processing of human microRNA
precursors. Mol. Cell, 16, 861–865.
4. Kim,V.N. (2005) MicroRNA biogenesis: coordinated cropping and
dicing. Nat. Rev. Mol. Cell. Biol., 6, 376–385.
5. Carmell,M.A. and Hannon,G.J. (2004) RNase III enzymes and the
initiation of gene silencing. Nat. Struct. Mol. Biol., 11, 214–218.
6. Meister,G. and Tuschl,T. (2004) Mechanisms of gene silencing by
double-stranded RNA. Nature, 431, 343–349.
7. Griffiths-Jones,S. (2004) The microRNA registry. Nucleic Acids Res.,
32, D109–D111.
8. Lee,R.C., Feinbaum,R.L. and Ambros,V. (1993) The C.elegans
heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell, 75, 843–854.
9. Reinhart,B.J., Slack,F.J., Basson,M., Pasquinelli,A.E., Bettinger,J.C.,
Rougvie,A.E., Horvitz,H.R. and Ruvkun,G. (2000) The 21-nucleotide
let-7 RNA regulates developmental timing in Caenorhabditis elegans.
Nature, 403, 901–906.
10. Johnston,R.J. and Hobert,O. (2003) A microRNA controlling left/right
neuronal asymmetry in Caenorhabditis elegans. Nature, 426, 845–849.
11. Brennecke,J., Hipfner,D.R., Stark,A., Russell,R.B. and Cohen,S.M.
(2003) bantam encodes a developmentally regulated microRNA that
controls cell proliferation and regulates the proapoptotic gene hid in
Drosophila. Cell, 113, 25–36.
12. Xu,P., Vernooy,S.Y., Guo,M. and Hay,B.A. (2003) The Drosophila
microRNA Mir-14 suppresses cell death and is required for normal fat
metabolism. Curr. Biol., 13, 790–795.
13. Chen,C.Z., Li,L., Lodish,H.F. and Bartel,D.P. (2004) MicroRNAs
modulate hematopoietic lineage differentiation. Science, 303, 83–86.
14. Brennecke,J., Stark,A., Russell,R.B. and Cohen,S.M. (2005) Principles
of microRNA-target recognition. PLoS Biol., 3, e85.
162 Nucleic Acids Research, 2007, Vol. 35, No. 115. Doench,J.G. and Sharp,P.A. (2004) Specificity of microRNA target
selection in translational repression. Genes Dev., 18, 504–511.
16. Kiriakidou,M., Nelson,P.T., Kouranov,A., Fitziev,P., Bouyioukos,C.,
Mourelatos,Z. and Hatzigeorgiou,A. (2004) A combined
computational-experimental approach predicts human microRNA
targets. Genes Dev., 18, 1165–1178.
17. Kloosterman,W.P., Wienholds,E., Ketting,R.F. and Plasterk,R.H.
(2004) Substrate requirements for let-7 function in the developing
zebrafish embryo. Nucleic Acids Res., 32, 6284–6291.
18. Enright,A.J., John,B., Gaul,U., Tuschl,T., Sander,C. and Marks,D.S.
(2003) MicroRNA targets in Drosophila. Genome Biol., 5, R1.
19. John,B., Enright,A.J., Aravin,A., Tuschl,T., Sander,C. and Marks,D.S.
(2004) Human MicroRNA targets. PLoS Biol., 2, e363.
20. Kiriakidou,M., Nelson,P.T., Kouranov,A., Fitziev,P., Bouyioukos,C.,
Mourelatos,Z. and Hatzigeorgiou,A. (2004) A combined
computational-experimental approach predicts human microRNA
targets. Genes Dev., 18, 1165–1178.
21. Krek,A., Grun,D., Poy,M.N., Wolf,R., Rosenberg,L., Epstein,E.J.,
MacMenamin,P., da Piedade,I., Gunsalus,K.C., Stoffel,M. et al. (2005)
Combinatorial microRNA target predictions. Nat. Genet., 37, 495–500.
22. Lewis,B.P., Shih,I.H., Jones-Rhoades,M.W., Bartel,D.P. and
Burge,C.B. (2003) Prediction of mammalian microRNA targets. Cell,
115, 787–798.
23. Lewis,B.P., Burge,C.B. and Bartel,D.P. (2005) Conserved seed pairing,
often flanked by adenosines, indicates that thousands of human genes
are microRNA targets. Cell, 120, 15–20.
24. Rhoades,M.W., Reinhart,B.J., Lim,L.P., Burge,C.B., Bartel,B. and
Bartel,D.P. (2002) Prediction of plant microRNA targets. Cell, 110,
513–520.
25. Robins,H., Li,Y. and Padgett,R.W. (2005) Incorporating structure to
predict microRNA targets. Proc. Natl Acad. Sci. USA, 102, 4006–4009.
26. Stark,A., Brennecke,J., Russell,R.B. and Cohen,S.M. (2003)
Identification of Drosophila MicroRNA targets. PLoS Biol., 1, E60.
27. Wang,X.J., Reyes,J.L., Chua,N.H. and Gaasterland,T. (2004)
Prediction and identification of Arabidopsis thaliana microRNAs and
their mRNA targets. Genome Biol., 5, R65.
28. Lim,L.P., Lau,N.C., Garrett-Engele,P., Grimson,A., Schelter,J.M.,
Castle,J., Bartel,D.P., Linsley,P.S. and Johnson,J.M. (2005) Microarray
analysis shows that some microRNAs downregulate large numbers of
target mRNAs. Nature, 433, 769–773.
29. Krutzfeldt,J., Rajewsky,N., Braich,R., Rajeev,K.G., Tuschl,T.,
Manoharan,M. and Stoffel,M. (2005) Silencing of microRNAs in vivo
with ‘antagomirs’. Nature, 438, 685–689.
30. Inaoka,H., Fukuoka,Y. and Kohane,I.S. (2006) Lower expression of
genes near microRNA in C. elegans germline. BMC Bioinformatics.,
7, 112.
31. Laule,O., Hirsch-Hoffmann,M., Hruz,T., Gruissem,W. and
Zimmermann,P. (2006) Web-based analysis of the mouse
transcriptome using Genevestigator. BMC Bioinformatics.,
7, 311.
32. Oishi,K., Amagai,N., Shirai,H., Kadota,K., Ohkura,N. and Ishida,N.
(2005) Genome-wide expression analysis reveals 100 adrenal
gland-dependent circadian genes in the mouse liver. DNA Res., 12,
191–202.
33. Wang,H., Hubbell,E., Hu,J.S., Mei,G., Cline,M., Lu,G., Clark,T.,
Siani-Rose,M.A., Ares,M., Kulp,D.C. et al. (2003) Gene
structure-based splice variant deconvolution using a microarray
platform. Bioinformatics, 19, i315–i322.
34. Farh,K.K., Grimson,A., Jan,C., Lewis,B.P., Johnston,W.K., Lim,L.P.,
Burge,C.B. and Bartel,D.P. (2005) The widespread impact of
mammalian MicroRNAs on mRNA repression and evolution. Science,
310, 1817–1821.
35. Stark,A., Brennecke,J., Bushati,N., Russell,R.B. and Cohen,S.M.
(2005) Animal MicroRNAs confer robustness to gene expression
and have a significant impact on 30-UTR evolution. Cell, 123,
1133–1146.
36. Sood,P., Krek,A., Zavolan,M., Macino,G. and Rajewsky,N. (2006)
Cell-type-specific signatures of microRNAs on target mRNA
expression. Proc. Natl Acad. Sci. USA, 103, 2746–2751.
37. Arbeitman,M.N., Furlong,E.E., Imam,F., Johnson,E., Null,B.H.,
Baker,B.S., Krasnow,M.A., Scott,M.P., Davis,R.W. and White,K.P.
(2002) Gene expression during the life cycle of Drosophila
melanogaster. Science, 297, 2270–2275.
38. Johnson,J.M., Castle,J., Garrett-Engele,P., Kan,Z., Loerch,P.M.,
Armour,C.D., Santos,R., Schadt,E.E., Stoughton,R. and
Shoemaker,D.D. (2003) Genome-wide survey of human alternative
pre-mRNA splicing with exon junction microarrays. Science, 302,
2141–2144.
39. Zhang,W., Morris,Q.D., Chang,R., Shai,O., Bakowski,M.A.,
Mitsakakis,N., Mohammad,N., Robinson,M.D., Zirngibl,R.,
Somogyi,E. et al. (2004) The functional landscape of mouse gene
expression. J. Biol., 3, 21.
40. Wang,E. and Purisima,E. (2005) Network motifs are enriched with
transcription factors whose transcripts have short half-lives.
Trends Genet., 21, 492–495.
41. Babak,T., Zhang,W., Morris,Q., Blencowe,B.J. and Hughes,T.R.
(2004) Probing microRNAs with microarrays: tissue specificity and
functional inference. RNA, 10, 1813–1819.
42. Barad,O., Meiri,E., Avniel,A., Aharonov,R., Barzilai,A., Bentwich,I.,
Einav,U., Gilad,S., Hurban,P., Karov,Y. et al. (2004) MicroRNA
expression detected by oligonucleotide microarrays: system
establishment and expression profiling in human tissues. Genome Res.,
14, 2486–2494.
43. Baskerville,S. and Bartel,D.P. (2005) Microarray profiling of
microRNAs reveals frequent coexpression with neighboring miRNAs
and host genes. RNA, 11, 241–247.
44. Houbaviy,H.B., Murray,M.F. and Sharp,P.A. (2003) Embryonic stem
cell-specific MicroRNAs. Dev. Cell, 5, 351–358.
45. Krichevsky,A.M., King,K.S., Donahue,C.P., Khrapko,K. and
Kosik,K.S. (2003) A microRNA array reveals extensive regulation of
microRNAs during brain development. RNA, 9, 1274–1281.
46. Liu,C.G., Calin,G.A., Meloon,B., Gamliel,N., Sevignani,C.,
Ferracin,M., Dumitru,C.D., Shimizu,M., Zupo,S., Dono,M. et al.
(2004) An oligonucleotide microchip for genome-wide microRNA
profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA, 101,
9740–9744.
47. Miska,E.A., Alvarez-Saavedra,E., Townsend,M., Yoshii,A., Sestan,N.,
Rakic,P., Constantine-Paton,M. and Horvitz,H.R. (2004) Microarray
analysis of microRNA expression in the developing mammalian brain.
Genome Biol., 5, R68.
48. Nelson,P.T., Baldwin,D.A., Scearce,L.M., Oberholtzer,J.C.,
Tobias,J.W. and Mourelatos,Z. (2004) Microarray-based,
high-throughput gene expression profiling of microRNAs. Nat. Meth.,
1, 155–161.
49. Sempere,L.F., Freemantle,S., Pitha-Rowe,I., Moss,E., Dmitrovsky,E.
and Ambros,V. (2004) Expression profiling of mammalian microRNAs
uncovers a subset of brain-expressed microRNAs with possible roles in
murine and human neuronal differentiation. Genome Biol., 5, R13.
50. Thomson,J.M., Parker,J., Perou,C.M. and Hammond,S.M. (2004) A
custom microarray platform for analysis of microRNA gene expression.
Nature Meth., 1, 47–53.
51. Chen,J.F., Mandel,E.M., Thomson,J.M., Wu,Q., Callis,T.E.,
Hammond,S.M., Conlon,F.L. and Wang,D.Z. (2006) The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nature Genet., 38, 228–233.
52. Eis,P.S., Tam,W., Sun,L., Chadburn,A., Li,Z., Gomez,M.F., Lund,E.
and Dahlberg,J.E. (2005) Accumulation of miR-155 and BIC RNA in
human B cell lymphomas. Proc. Natl Acad. Sci. USA, 102, 3627–3632.
53. Kluiver,J., Poppema,S., de Jong,D., Blokzijl,T., Harms,G., Jacobs,S.,
Kroesen,B.J. and van den,B.A. (2005) BIC and miR-155 are highly
expressed in Hodgkin, primary mediastinal and diffuse large B cell
lymphomas. J. Pathol., 207, 243–249.
54. Zhao,Y., Samal,E. and Srivastava,D. (2005) Serum response factor
regulates a muscle-specific microRNA that targets Hand2 during
cardiogenesis. Nature, 436, 214–220.
55. Wienholds,E., Kloosterman,W.P., Miska,E., Alvarez-Saavedra,E.,
Berezikov,E., de Bruijn,E., Horvitz,H.R., Kauppinen,S. and
Plasterk,R.H. (2005) MicroRNA expression in zebrafish embryonic
development. Science, 309, 310–311.
56. Yang,W.J., Yang,D.D., Na,S., Sandusky,G.E., Zhang,Q. and Zhao,G.
(2005) Dicer is required for embryonic angiogenesis during mouse
development. J. Biol. Chem., 280, 9330–9335.
57. Bernstein,E., Kim,S.Y., Carmell,M.A., Murchison,E.P., Alcorn,H.,
Li,M.Z., Mills,A.A., Elledge,S.J., Anderson,K.V. and Hannon,G.J.
(2003) Dicer is essential for mouse development. Nature Genet., 35,
215–217.
Nucleic Acids Research, 2007, Vol. 35, No. 1 16358. Giraldez,A.J., Cinalli,R.M., Glasner,M.E., Enright,A.J., Thomson,J.M.,
Baskerville,S., Hammond,S.M., Bartel,D.P. and Schier,A.F. (2005)
MicroRNAs regulate brain morphogenesis in zebrafish. Science, 308,
833–838.
59. Wienholds,E., Koudijs,M.J., van Eeden,F.J., Cuppen,E. and
Plasterk,R.H. (2003) The microRNA-producing enzyme Dicer1 is
essential for zebrafish development. Nature Genet., 35, 217–218.
60. Lagos-Quintana,M., Rauhut,R., Yalcin,A., Meyer,J.,
Lendeckel,W. and Tuschl,T. (2002) Identification of
tissue-specific microRNAs from mouse. Curr. Biol., 12,
735–739.
61. Chen,C.Z., Li,L., Lodish,H.F. and Bartel,D.P. (2004)
MicroRNAs modulate hematopoietic lineage differentiation.
Science, 303, 83–86.
164 Nucleic Acids Research, 2007, Vol. 35, No. 1